A report of a case of motor neuropathy in a patient who received the vaccine last year has led the FDA to halt its ...
The approval of Hympavzi makes it the first treatment for both hemophilia A and B to be administered through a pre-filled pen ...
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has recently opened its new ...
From exploring the wonders of plants as a curious teen to leading global initiatives at SCIEX, Gitte Barknowitz has carved ...
Jane Koo, head of regulatory affairs at CTMC, plays an important role in accelerating the development and commercialization ...
The Japanese big pharma adds the new gene therapy candidate to its pipeline in a US$50 million deal in equity and upfront ...
At the forefront of precision dosing, Sharmeen leads DoseMe's efforts to transform personalized medicine from lab research to ...
Evaxion’s proprietary AI-Immunology platform has shown in clinical trials that it can select clinically relevant cancer vaccine targets. Danish techbio company Evaxion Biotech has published results ...
George White is the General Manager of Cell Therapy at Cytiva, a global biomanufacturing organization headquartered in the U.S. and part of Danaher. In this Q&A with Biopharma Reporter, White ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback